Senador Laboratories is a finished-dose manufacturer based in India. It appears in 39 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with MCAZ (ZW), EFDA (ET) and ARCSA (EC). Its GMP standing is certified by EMA and ANVISA (Brazil). Its most recent recorded inspection, by US FDA, closed on 16 September 2019 as NAI. Customs aggregates show $71.5M of exports covering 831 molecules to 99 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| AHMEDABAD, India | Not on file |
| Sarigam, India | Not on file |
| Ahmedabad, India | 3008725987 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| MCAZ (ZW) | 12 | None |
| EFDA (ET) | 8 | None |
| ARCSA (EC) | 8 | None |
| TMDA (TZ) | 5 | None |
| ZAMRA (ZM) | 4 | None |
| MINSA (CR) | 2 | None |
| EMA | None | 4 |
| ANVISA (Brazil) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $7.7M | 35 |
| 2025 | Not reported | $71.5M | 99 |
| 2024 | Not reported | $41.9M | 74 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Senador Laboratories comes back tiered against every other supplier able to file there.
Start for free